Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine
- PMID: 27370527
- PMCID: PMC5094181
- DOI: 10.1016/j.drugalcdep.2016.06.011
Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine
Abstract
Background: Coverage with opioid agonist treatments (OAT) that include methadone and buprenorphine is low (N=8400, 2.7%) for the 310,000 people who inject drugs (PWID) in Ukraine. In the context of widespread negative attitudes toward OAT in the region, patient-level interventions targeting the barriers and willingness to initiate OAT are urgently needed.
Methods: A sample of 1179 PWID with opioid use disorder not currently on OAT from five regions in Ukraine was assessed using multivariable logistic regression for independent factors related to willingness to initiate OAT, stratified by their past OAT experience.
Results: Overall, 421 (36%) PWID were willing to initiate OAT. Significant adjusted odds ratios (aOR) for covariates associated with the willingness to initiate OAT common for both groups included: higher injection frequency (previously on OAT: aOR=2.7; never on OAT: aOR=1.8), social and family support (previously on OAT: aOR=2.0; never on OAT: aOR=2.0), and positive attitude towards OAT (previously on OAT: aOR=1.3; never on OAT: aOR=1.4). Among participants previously on OAT, significant correlates also included: HIV-negative status (aOR=2.6) and depression (aOR=2.7). Among participants never on OAT, however, living in Kyiv (aOR=4.8) or Lviv (aOR=2.7), previous imprisonment (aOR=1.5), registration at a Narcology service (aOR=1.5) and recent overdose (aOR=2.6) were significantly correlated with willingness to initiate OAT.
Conclusions: These findings emphasize the need for developing interventions aimed to eliminate existing negative preconceptions regarding OAT among PWID with opioid use disorder in Ukraine, which should be tailored to meet the needs of specific characteristics of PWID in geographically distinct setting based upon injection frequency, prior incarceration, and psychiatric and HIV status.
Keywords: Drug injection; HIV; Opioid agonist treatments; Opioid use disorder; Ukraine.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
We have no conflict of interest to declare
References
-
- Altice FL, Azbel L, El-Bassel N, Dvoryak S, Stover H, Brooks-Pollard E, Martin N, Booth R, Smyrnov P, Taxman FS, Dolan K, Vickerman P. The perfect storm: incarceration and multi-level contributors to perpetuating HIV and tuberculosis in Eastern Europe and Central Asia. Lancet. 2016 In Press. - PMC - PubMed
-
- Amodeo M, Chassler D, Ferguson F, Fitzgerald T, Lundgren L. Use of mental health and substance abuse treatment services by female injection drug users. Am J Drug Alcohol Abuse. 2004;30:101–120. - PubMed
-
- Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale) Am J Prev Med. 1994;10:77–84. - PubMed
-
- Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test (AUDIT) World Health Organization, Department of Mental Health and Substance Dependence; Geneva: 2001.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous